Isomorphic Labs & Alphabet Inc.
3 shared events · Importance 3 · Last updated Aug 07, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Business
Isomorphic Labs: Isomorphic Labs, the AI drug discovery company, remains under Hassabis's leadership. He will spend more time there, potentially accelerating its work in biomedical applications.
Alphabet Inc.: Alphabet Inc. is the operating company undergoing the AI leadership overhaul. It is losing key AI researchers and faces delays in its flagship Google Gemini model, impacting its competitive position.
Aug 05, 2026 · 86 articles
Tech
Isomorphic Labs: Isomorphic Labs, Alphabet's drug discovery spinout, gains some former AlphaFold researchers, potentially benefiting from their expertise.
Alphabet Inc.: Alphabet, as parent company, sees a strategic realignment of its AI research, with potential long-term implications for its competitive position in AI.
Jul 29, 2026 · 7 articles
Business
Isomorphic Labs: Some members of John Jumper's protein-folding research team have moved to Isomorphic Labs, an Alphabet spinout, indicating internal talent shifts within Alphabet's AI ecosystem.
Alphabet Inc.: Alphabet Inc. is losing key AI researchers to competitors, which could undermine its position in the competitive AI market and negatively impact its stock performance.
Jun 24, 2026 · 14 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how Isomorphic Labs and Alphabet Inc. interact across events, view sentiment trends, and discover connected entities.
Open Dashboard